¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Walker carcinoma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hepatocellular carcinoma
    °£¼¼Æ÷¾ÏÁ¾
  • invasive carcinoma
    ħ½À¾ÏÁ¾
  • islet cell carcinoma
    ¼¶¼¼Æ÷¾ÏÁ¾
  • inflammatory carcinoma
    ¿°ÁõÇü¾ÏÁ¾
  • intraductal carcinoma
    °ü³»¾ÏÁ¾
  • intraepithelial carcinoma
    »óÇdz»¾Ï(Á¾)
  • large cell carcinoma
    ´ë¼¼Æ÷¾ÏÁ¾, Å«¼¼Æ÷¾ÏÁ¾
  • mucinous carcinoma
    Á¡¾×¾ÏÁ¾
  • medullary carcinoma
    ¼ÓÁú¾ÏÁ¾, ¼öÁú¾ÏÁ¾
  • metaplastic carcinoma
    È­»ý¾ÏÁ¾
  • metastatic carcinoma
    ÀüÀ̾ÏÁ¾
  • microcystic carcinoma
    ¹Ì¼¼³¶¾ÏÁ¾
  • microinvasive carcinoma
    ¹Ì¼¼Ä§À±¾ÏÁ¾
  • neuroendocrine carcinoma
    ½Å°æ³»ºÐºñ¾ÏÁ¾
  • non-small cell carcinoma
    ºñ¼Ò¼¼Æ÷¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • intraepithelial carcinoma
    »óÇdz»¾ÏÁ¾, Ç¥ÇǼӾÏÁ¾
  • invasive carcinoma
    ħ½À¾ÏÁ¾
  • islet cell carcinoma
    ¼¶¼¼Æ÷¾ÏÁ¾
  • large cell carcinoma
    Å«¼¼Æ÷¾ÏÁ¾, ´ë¼¼Æ÷¾ÏÁ¾
  • medullary carcinoma
    ¼ÓÁú¾ÏÁ¾, ¼öÁú¾ÏÁ¾
  • metastatic carcinoma
    ÀüÀ̾ÏÁ¾
  • microcystic carcinoma
    ¹Ì¼¼³¶¾ÏÁ¾
  • microinvasive carcinoma
    ¹Ì¼¼Ä§À±¾ÏÁ¾
  • mucinous carcinoma
    Á¡¾×¾ÏÁ¾
  • mucous carcinoma
    (¢¡mucinous carcinoma) Á¡¾×¾ÏÁ¾
  • nasopharyngeal carcinoma
    ÄÚÀεξÏÁ¾
  • neuroendocrine carcinoma
    ½Å°æ³»ºÐºñ¾ÏÁ¾
  • oat cell carcinoma
    ±Í¸®¼¼Æ÷¾ÏÁ¾
  • papillary carcinoma
    À¯µÎ¾ÏÁ¾
  • primary carcinoma
    ¿ø¹ß¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • prostate,grading of prostate carcinoma
    Àü¸³¼±¼±¾ÏÁ¾µî±Þ(îñí¡àÍàÍäßðþÔõÐä)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • breast,carcinoma infiltrating duct
    ħÀ±¼º °ü»ó (öÙëÈàõηßÒ)
  • breast,carcinoma intraductal
    °ü³»(ηҮ)
  • breast,carcinoma inverted nipples
    ÇÔ¸ôÀ¯µÎ (ùèÙÒêáÔé)
  • breast,carcinoma lobular
    ¼Ò¿± (á³ç¨)
  • breast,carcinoma lobular, in situ
    ¼Ò¿±¼º, ºñħÀ±¼º
  • breast,carcinoma mammography
    À¯¹æ Á¶¿µ¼ú (êáÛ®ðãç¯âú)
  • breast,carcinoma medullary
    ¼öÁú¼º (âÐòõàõ)
  • breast,carcinoma papillomatosis
    À¯µÎÁ¾Áõ (êáÔéðþñø)
  • breast,carcinoma scirrhous
    °æÁú¼º (Ìãòõàõ)
  • brochioloalveolar carcinoma
    ¼¼±â°üÁö ÆóÆ÷¾ÏÁ¾(á¬Ñ¨Î·ò¨øËøàäßðþ)
  • bronchiolar carcinoma
    ¼¼±â°üÁö¼º ¾Ï(Á¾)(¡­àõäßðþ).
  • bronchogenic carcinoma
    ±â°üÁö¿ø¼º ¾ÏÁ¾(¡­äßðþ).
  • bronchogenic carcinoma
    ±â°üÁö¿ø¼º ¾ÏÁ¾(¡­äßðþ)
  • carcinoma
    ¾ÏÁ¾
  • carcinoma
    ¾ÏÁ¾ (äßðþ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BCC Basal Cell Carcinoma
Ca   1) Carcinoma
  2) Cancer; ¾Ï
  3) Calcium
CIS Carcinoma In Situ
FMTC Familial Medullary Thyroid Carcinoma
MTC Medullary Thyroid Carcinoma
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BCC Basal Cell Carcinoma
BSC Basaloid Squamous Carcinoma
BSCC Basaloid squamous cell carcinoma
BOSCC Bovine ocular squamous cell carcinoma
BAC Bronchiolo-alveolar carcinoma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • clear cell basal cell carcinoma
    Åõ¸í ¼¼Æ÷ ±âÀú¼¼Æ÷¾Ï
  • colloid carcinoma
    ÄÝ·ÎÀ̵强 ¾ÏÁ¾
  • colorectal carcinoma
    °áÀå Á÷Àå¾Ï
  • columnar cell carcinoma
    ¿øÁÖ ¼¼Æ÷ ¾ÏÁ¾
  • cutaneous metastatic carcinoma
    ÇǺΠÀüÀÌ ¾Ï, ÇǺΠÀüÀÌ ¾ÏÁ¾
  • duct carcinoma
    °ü ¾ÏÁ¾
  • embryonal carcinoma
    ¹è¾Æ¼º ¾ÏÁ¾
    °íȯ¿¡ »ý±â´Â °°Àº Á¾·ùÀÇ ¾ÏÁ¾º¸´Ù´Â ´ú ÈçÈ÷ ³­¼Ò¿¡ ¹ß»ýÇÏ°í ¾î¸°ÀÌ¿Í ÀþÀº ¿©¼º¿¡ È£¹ßÇÑ´Ù. Á¶Á÷ÇÐÀûÀ¸·Î ¹Ì¼º¼÷ »óÇÇ ¼¼Æ÷µéÀÌ ¹Ì¸¸¼º ¶Ç´Â ¼±»ó ÇüÅ·Π¹è¿­µÈ´Ù. À¶ÇÕ ¼¼Æ÷ ¿µ¾ç¸· °Å´ë ¼¼Æ÷°¡ ´ëºÎºÐ ÃâÇöÇÏ¿© HCG¿¡ ¾ç¼ºÀ̰í Å»ý±â ¾Ï ¼¼Æ÷´Â ¾ËÆÄ ÅÂ¾Æ ´Ü¹é¿¡ ¾ç¼ºÀÌ´Ù.
  • endometrial carcinoma
    Àڱà ³»¸· ¾ÏÁ¾
    ÇϳªÀÇ ±ºÀº Áö¼ÓÀûÀÎ ¿¡½ºÆ®·Î°Õ Àڱذú Àڱ󻸷 °úÇü¼ºÀÇ ¹è°æ¿¡¼­ ¹ß»ýÇÑ´Ù´Â °ÍÀÌ´Ù. Àڱ󻸷 °úÇü¼º°ú ¾ÏÁ¾Àº ºñ¸¸°ú ¹«¹è¶õ ÁÖ±â¿Íµµ À¯°üÇÏ´Ù. ÀÌ·¯ÇÑ ÀÎÀÚµé°ú ¿¬°üµÇ¾î ¹ß»ýÇÑ ³»¸· ¾ÏÀº ºÐÈ­°¡ ÁÁÀº °æÇâÀÌ ÀÖ°í ÇüÅÂÇÐÀûÀ¸·Î Á¤»ó ³»¸·¼±°ú À¯»çÇÑ "Àڱ󻸷¾ç
  • epithelial carcinoma
    »óÇÇ ¾ÏÁ¾
  • fibrosing basal cell carcinoma
    ¼¶À¯¼º ±âÀú ¼¼Æ÷ ¾Ï
  • infiltrating duct breast carcinoma
    ħÀ±¼º °ü»ó À¯¹æ ¾Ï
  • intraductal carcinoma
    ¼±°ü³» ¾Ï
  • invasive carcinoma
    ħ½À¼º ¾ÏÁ¾
  • invasive squamous cell carcinoma
    ħÀÔ¼º ÆíÆò »óÇÇ ¼¼Æ÷ ¾Ï
  • inverted nipples breast carcinoma
    ÇÔ¸ô À¯µÎ À¯¹æ ¾Ï
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
carcinoma <oncology> A malignant new growth that arises from epithelium, found in skin or, more commonly, the lining of body organs, for example: breast, prostate, lung, stomach or bowel. Carcinomas tend to infiltrate into adjacent tissue and spread (metastasize) to distant organs, for example: to bone, liver, lung or the brain.
Origin: Gr. Karkinoma from karkinos = crab, cancer
(16 Dec 1997)
carcinoma, acinar cell A malignant tumour arising from secreting cells of a racemose gland, particularly the salivary glands. Racemose (latin racemosus, full of clusters) refers, as does acinar (latin acinus, grape), to small saclike dilatations in various glands. Acinar cell carcinomas are usually well differentiated and account for about 13% of the cancers arising in the parotid gland. Lymph node metastasis occurs in about 16% of cases. Local recurrences and distant metastases many years after treatment are common. This tumour appears in all age groups and is most common in women.
(12 Dec 1998)
carcinoma, adenoid cystic Carcinoma characterised by bands or cylinders of hyalinised or mucinous stroma separating or surrounded by nests or cords of small epithelial cells. When the cylinders occur within masses of epithelial cells, they give the tissue a perforated, sievelike, or cribriform appearance. Such tumours occur in the mammary glands, the mucous glands of the upper and lower respiratory tract, and the salivary glands. They are malignant but slow-growing, and tend to spread locally via the nerves.
(12 Dec 1998)
carcinoma, adenosquamous A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.
(12 Dec 1998)
carcinoma, adrenal cortical A malignant neoplasm of adrenal cortical cells demonstrating partial or complete histological and functional differentiation. They are rare, comprising between only 0.05% and 0.2% of all cancers. Women develop functional adrenal cortical carcinomas more commonly than men, but men develop nonfunctioning ones more often than women. Hypercortisolism is the most common presentation for this cancer. Virilism and cushing's syndrome may also result.
(12 Dec 1998)
carcinoma, basal cell A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). More than 95% of these carcinomas occur in patients over 40. They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs.
(12 Dec 1998)
carcinoma, basosquamous A skin carcinoma that histologically exhibits both basal and squamous elements.
(12 Dec 1998)
carcinoma, bronchogenic A cancer of the lung, so-called because it arises from the epithelium of the bronchial tree. It is not a histologic designation despite the name.
(12 Dec 1998)
carcinoma, ehrlich tumour A transplantable, poorly differentiated malignant tumour which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.
(12 Dec 1998)
carcinoma, embryonal A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular tumours.
(12 Dec 1998)
carcinoma, endometrioid Ovarian carcinoma which resembles typical carcinoma of the endometrium and may be seen with a synchronous endometrial carcinoma. When they appear together, both tend to be of low stage.
(12 Dec 1998)
carcinoma ex pleomorphic adenoma <tumour> Carcinoma arising in a benign mixed tumour of a salivary gland, characterised by rapid enlargement and pain.
(05 Mar 2000)
carcinoma, giant cell An epithelial neoplasm characterised by unusually large anaplastic cells. It is highly malignant with fulminant clinical course, bizarre histologic appearance and poor prognosis. It is most common in the lung and thyroid.
(12 Dec 1998)
carcinoma, hepatocellular Primary carcinoma of the liver cells. It ranges from a well-differentiated tumour difficult to distinguish from normal hepatocytes to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic or may form giant cells. Several classification schemes have been suggested. Hepatocellular carcinoma is very rare in the united states and western europe, but it is one of the most common cancers in eastern asia and sub-saharan africa. The cases are preponderantly male and, racially, whites have the lowest rates.
(12 Dec 1998)
carcinoma, infiltrating duct An invasive (infiltrating) carcinoma of the breast. This carcinoma in which no special histological feature is recognised is designated nos or not otherwise specified and is by far the most common ductal tumour, accounting for almost 70% of breast cancers. It is characterised by stony hardness upon palpation. It commonly metastasizes to the axillary lymph nodes and its prognosis is the poorest of the various ductal types.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á